Big drug makers have more cash from the tax overhaul, but it's likely for deals - STAT

Big drug makers have more cash from the tax overhaul, but it's likely for deals - STAT

STAT Plus: Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

By ED SILVERMAN

JON ELSWICK/AP

Drug makers generated more cash from normal operating activities than they spent, and this signals more M&A opportunities, a Moody's analyst says.

READ MORE